Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Regulatory News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,742.50
Bid: 1,742.50
Ask: 1,743.00
Change: 9.00 (0.52%)
Spread: 0.50 (0.029%)
Open: 1,736.00
High: 1,750.00
Low: 1,736.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Block Listing Application

10 Dec 2020 11:55

RNS Number : 2455I
GlaxoSmithKline PLC
10 December 2020
 

GlaxoSmithKline plc

 

 

Block listing Application

 

Application has been made to the Financial Conduct Authority and the London Stock Exchange plc for a total of 660,000 Ordinary Shares of 25p each ('Shares') to be admitted to the Official List.

 

The Shares are being reserved under a block listing and will be issued under the GlaxoSmithKline plc Share Save Plan 2012 and GlaxoSmithKline plc 2017 Deferred Annual Bonus Plan.

 

When issued, the Shares will rank pari passu with the existing Ordinary Shares of 25p each.

 

Admission is expected to be effective on 11 December 2020.

 

 

 

Victoria Whyte

Company Secretary

 

10 December 2020

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ALSFLFELFELILII
Date   Source Headline
21st Dec 20223:30 pmRNSDirector/PDMR Shareholding
15th Dec 20223:30 pmRNSBoard and Committee Changes
13th Dec 20223:30 pmRNSDirector/PDMR Shareholding
7th Dec 20227:00 amRNSStatement: Zantac (ranitidine) litigation
5th Dec 20224:00 pmRNSTransfer of Treasury Shares
2nd Dec 20223:30 pmRNSDirector/PDMR Shareholding
2nd Dec 20227:00 amRNSEMA file accepted for momelotinib
2nd Dec 20227:00 amRNSJemperli positive trial in endometrial cancer
1st Dec 20223:00 pmRNSTotal Voting Rights
25th Nov 20224:47 pmRNSPublication of Final Terms of EMTN Notes
24th Nov 20223:00 pmRNSGSK publishes provisional 2023 dividend dates
22nd Nov 20224:00 pmRNSPublication of Supplementary EMTN Prospectus
22nd Nov 20227:00 amRNSBlenrep US Update
21st Nov 20223:30 pmRNSDirector/PDMR Shareholding
18th Nov 20224:00 pmRNSPublication of EMTN Supplementary Prospectus
15th Nov 20224:00 pmRNSBlock listing Interim Review
15th Nov 20223:53 pmRNSFinal results of outstanding Notes Tender Offer
15th Nov 20227:00 amRNSInterim results of outstanding Notes Tender Offer
11th Nov 20227:00 amRNSGSK Update: Zejula 2L in US
10th Nov 20226:10 pmRNSSanofi-GSK COVID booster vaccine approved by EU
10th Nov 20223:30 pmRNSDirector/PDMR Shareholding
10th Nov 20229:00 amRNSBlock Listing Application
8th Nov 20229:26 amRNSLaunch of Tender Offer for outstanding Notes
7th Nov 20227:00 amRNSDREAMM-3 phase III trial for Blenrep
3rd Nov 20221:00 pmRNSPublication of Suppl.Prospcts
3rd Nov 20227:00 amRNSIDMC recommends gepotidacin early efficacy stop
2nd Nov 20227:01 amRNS3rd Quarter Results
2nd Nov 20227:00 amRNSGSK RSV vaccine: US FDA Priority Review
1st Nov 20223:00 pmRNSTotal Voting Rights
28th Oct 20227:00 amRNSEMA validates MAA for cabotegravir LA for PrEP
28th Oct 20227:00 amRNSEMA accepts GSK RSV older adult vaccine for review
27th Oct 20227:05 amRNSGSK announces FDA meeting outcome on daprodustat
27th Oct 20227:00 amRNSContRAst phase III programme for otilimab update
25th Oct 202210:00 amRNSBoard Committee Changes
21st Oct 20227:00 amRNSRSV older adult vaccine submission in Japan
17th Oct 20227:00 amRNSMenveo new single-vial approve by US FDA
17th Oct 20227:00 amRNSMenveo new single-vial approved by US FDA
14th Oct 20222:11 pmRNSDirector/PDMR Shareholding
13th Oct 202212:46 pmRNSDirector/PDMR Shareholding
13th Oct 20229:44 amRNSDirector/PDMR Shareholding
13th Oct 20228:26 amRNSDirector/PDMR Shareholding
13th Oct 20227:00 amRNSEfficacy results for GSK’s older adult RSV vaccine
12th Oct 202211:42 amRNSDirector/PDMR Shareholding
10th Oct 20227:00 amRNSUS FDA approves Boostrix maternal immunisation
7th Oct 20224:38 pmRNSDirector/PDMR Shareholding
7th Oct 20224:24 pmRNSDirector/PDMR Shareholding
3rd Oct 202210:10 amRNSTotal Voting Rights
30th Sep 20225:21 pmRNSDirector/PDMR Shareholding
26th Sep 20225:09 pmRNSDirector/PDMR Shareholding
26th Sep 20227:00 amRNSGSK Chief Financial Officer succession

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.